GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is currently emerging as a significant focus in therapeutic research, largely due to its impressive impact on treating conditions such as type 2 diabetes and excess body fat. New research have revealed that beyond glucose regulation, GLP-1 medications offer promise for circulatory function